AU · rank #17 · 2026-09-08
CHYM
NASDAQ · $12.78B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 0.705 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$0.14 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 10 |
| Insider signal (90d) $0 across 0 unique buyers. | -0.186 |
| Analyst upside Consensus target $35.05 | +3.8% |
| Momentum acceleration 3-month minus 12-month momentum. | +95.82% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | — |
| Gross margin TTM | +88.7% |
| 52w high | $34.44 |
| Market cap (USD) | $12.78B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Chime Financial (CHYM) is a US mobile-first neobank generating transaction-based revenue from ~10.4 million active members via spending accounts, debit cards, and related consumer fintech services.
Rationale
The analyst_upside strategy is reinforced by 13 target raises in 30 days, 86% revision agreement among 17 analysts, a 345% earnings surprise in Q2 2026, and consecutive quarters of GAAP profitability driving legitimate upward estimate momentum rather than mere sentiment rotation.
Material risks
- 1Interchange and transaction-based revenue concentration means any regulatory cap on debit interchange fees (e.g., Durbin Amendment expansion) could directly compress the ~89% gross margin and invalidate the profitability inflection thesis in a single regulatory action.
- 2Zero insider buying over 90 days alongside a CFO transition and restructuring announcement introduces execution uncertainty precisely when the market is pricing in a clean profitable-growth narrative.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.